Nephrotic syndrome and autosomal dominant polycystic kidney disease

By Visciano Bianca   Di Pietro Renata A.   Rossano Roberta   Mancini Antonio   Zamboli Pasquale   Cianciaruso Bruno   Pisani Antonio  

Clinical Kidney Journal, Vol. 5, Iss. 6, 2012-12 ,pp. : 508-511

Oxford University Press

Access to resources Recommend Favorite

Impairment of heart rate recovery index in autosomal-dominant polycystic kidney disease patients without hypertension

By Orscelik Ozcan   Kocyigit Ismail   Baran Oguzhan   Kaya Coskun   Dogdu Orhan   Zengin Halit   Karadavut Serhat   Gedikli Omer   Kut Engin   Duran Mustafa   Calapkorur Bekir   Tokgoz Bulent   Kaya Mehmet Gungor  

Blood Pressure, Vol. 21, Iss. 5, 2012-10 ,pp. : 300-305

Informa Healthcare

Access to resources Recommend Favorite

mTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): the question remains open

By Jardine Meg J.   Liyanage Thaminda   Buxton Erin   Perkovic Vlado  

Nephrology Dialysis Transplantation, Vol. 28, Iss. 2, 2013-02 ,pp. : 242-244

Oxford University Press

Access to resources Recommend Favorite

Bilateral Emphysematous Pyelonephritis and Emphysematous Cystitis with Autosomal-Dominant Polycystic Kidney Disease: Is Conservative Management Justified?

By  

Medical Principles and Practice, Vol. 16, Iss. 2, 2007-02 ,pp. : 155-157

Karger

Access to resources Recommend Favorite

Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials

By  

Current Hypertension Reviews, Vol. 13, Iss. 2, 2018-01 ,pp. : 109-120

Bentham Science Publishers

Access to resources Recommend Favorite